Concepedia

Shaunita A. Michael

SA

Statistics

Publications

3

Citations

68

H-Index

3

Active since

2012

Affiliations

Vanderbilt University Medical Center(Current)

Roswell Park Comprehensive Cancer Center

Arqule (United States)

Shaunita A. Michael is an author at Vanderbilt University Medical Center specializing in oncology, cancer pharmacology, and targeted therapy.

Publications per year

2012–2012

3

Publications

3

Safety and Pharmacokinetics of Ganitumab (AMG 479) Combined with Sorafenib, Panitumumab, Erlotinib, or Gemcitabine in Patients with Advanced Solid Tumors

Lee S. Rosen, Igor Puzanov, Gregory Friberg et al. · Clinical Cancer Research · 2012 · 34 citations · Full text

, , +17

Safety and efficacy of MET inhibitor tivantinib (ARQ 197) combined with sorafenib in patients (pts) with hepatocellular carcinoma (HCC) from a phase I study.

Robert E. Martell, Igor Puzanov, Wen Wee et al. · Journal of Clinical Oncology · 2012 · 19 citations

, , +15

Safety and efficacy of MET inhibitor tivantinib (ARQ 197) combined with sorafenib in patients (pts) with <i>NRAS</i> wild-type or mutant melanoma from a phase I study.

Julie A. Means‐Powell, Alex A. Adjei, Igor Puzanov et al. · Journal of Clinical Oncology · 2012 · 15 citations

, , +17

1–3 of 3